
Sample Sprint deliverable
Example Market Entry Sprint output
This is the structure of a GHMAP Market Entry Sprint package: source status, evidence gaps, country questions, and next actions. Example only — not a real regulatory or reimbursement conclusion.

Sample Sprint deliverable
Example only — source status, evidence gaps, and next actions without regulatory conclusions.
Demo brief for product illustration only. Source verification and professional review required before business use.
A paid Market Entry Sprint delivers a reviewed package for your product and target country in 10 business days, plus a 60-minute review call. See pricing.
Country comparison dashboard
Country questions stay separated from conclusions.
This demo shows the type of country-by-country question structure GHMAP can organize. It does not provide actual regulatory, reimbursement, payer, procurement, or pricing conclusions.
| Country | Regulatory question | Reimbursement question | Payer/procurement question | Evidence gap | Required source type | Status | Next action |
|---|---|---|---|---|---|---|---|
| Germany | Confirm applicable pathway with official source. | Identify payer or reimbursement route requiring verification. | Map public/private payer or procurement process. | Local evidence expectations to verify. | Official regulator / payer / HTA / procurement source required. | To verify | Attach source and assign reviewer. |
| UAE | Confirm applicable pathway with official source. | Identify payer or reimbursement route requiring verification. | Map public/private payer or procurement process. | Local evidence expectations to verify. | Official regulator / payer / HTA / procurement source required. | To verify | Attach source and assign reviewer. |
| Saudi Arabia | Confirm applicable pathway with official source. | Identify payer or reimbursement route requiring verification. | Map public/private payer or procurement process. | Local evidence expectations to verify. | Official regulator / payer / HTA / procurement source required. | To verify | Attach source and assign reviewer. |
Evidence readiness matrix
Evidence gaps become reviewable work items.
The matrix keeps each evidence category tied to a country, source requirement, owner role, and current status.
| Evidence area | Germany | UAE | Saudi Arabia | Required source | Owner role | Status |
|---|---|---|---|---|---|---|
| Product classification | Source required | To verify | Source required | Official regulator source | Regulatory reviewer | Incomplete |
| Clinical evidence | To verify | Source required | To verify | Approved evidence package | Clinical evidence reviewer | Professional review required |
| Economic evidence | Source required | To verify | Source required | Economic evidence source | Health economics reviewer | Incomplete |
| Local payer expectations | To verify | To verify | Source required | Payer / reimbursement source | Reimbursement reviewer | Source required |
| Procurement/tender evidence | Demo only | Source required | To verify | Procurement / tender source | Procurement reviewer | Source required |
| Competitor context | Example only | Example only | Example only | Verified market context source | Market-access analyst | Demo only |
| Local expert review | Professional review required | Professional review required | Professional review required | Reviewer note | Local expert reviewer | Professional review required |
Review workflow timeline
A brief stays locked until source and professional review work is complete.
Most stages in this public demo remain marked demo, incomplete, or locked so the output does not imply reliance-ready content.
Source requirements identified
Example onlyEvidence attached
Incompletesource-checked output
Demo previewReviewer assigned
To verifyProfessional review completed
Not completedExport approved
Locked
draft output format
Source-aware preview
Summary
GHMAP would summarize attached, approved sources here.
Assumptions
Assumptions remain unverified until sources are attached.
Missing evidence
Official sources required before business reliance.
Source list
No verified source attached in this demo.
Confidence
Demo only / insufficient for reliance.
Human review required
Professional review required.
Recommended next actions
Attach sources, assign reviewer, confirm country-specific pathway.
Export preview
Export available after source review.
Export actions are disabled in this public demo. The brief remains locked until source review and professional review are complete.
Source governance
Source status, evidence gaps, review needs, and next actions stay visible before export.
Request the real deliverable
Start a Market Entry Sprint for your product and country
$2,500 · 10 business days · pathway outline, reimbursement and evidence flags, gaps, next actions, and a review call.
Example output shown. A real Market Entry Sprint is scoped for one product and one country.
